Anoro Ellipta

Generic name: Umeclidinium And Vilanterol
Drug class: Bronchodilator combinations

Usage of Anoro Ellipta

Anoro Ellipta is an inhalation powder containing a combination of umeclidinium and vilanterol. Umeclidinium and vilanterol both work by relaxing muscles in the airways to improve breathing.

Anoro Ellipta is used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

Anoro Ellipta is for use only in people with COPD and should not be used to treat asthma.

Anoro Ellipta side effects

Get emergency medical help if you have signs of an allergic reaction to Anoro Ellipta: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

wheezing, choking, or other breathing problems after using this medicine;

painful or difficult urination, or urinating more often;

blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights;

high blood sugar - increased thirst or urination, hunger, dry mouth, fruity breath odor; or

low potassium level - leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling.

Common Anoro Ellipta side effects may include:

stuffy nose, sinus pain, sore throat;

chest pain, cough;

diarrhea, constipation;

muscle spasms; or

pain in your neck, arms, or legs.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Anoro Ellipta

You should not use Anoro Ellipta if you are allergic to umeclidinium or vilanterol, or if you have a severe allergy to milk proteins.

To make sure Anoro Ellipta is safe for you, tell your doctor if you have ever had:/p>

heart disease, high blood pressure;

a seizure;

liver disease;

glaucoma;

diabetes;

a thyroid disorder; or

an enlarged prostate or urination problems.

Tell your doctor if you are pregnant or breastfeeding.

Anoro Ellipta is not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Anoro Ellipta

Anoro Ellipta is given as 1 inhalation once daily at the same time every day. It should not be used more than once in 24 hours.

Warnings

Anoro Ellipta is for use only in people with chronic obstructive pulmonary disease (COPD) and should not be used to treat asthma.

Anoro Ellipta is not a rescue medicine. It will not work fast enough to treat an bronchospasm attack. Tell your doctor if any of your medicines seem to stop working as well in controlling your COPD.

Vilanterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

Anoro Ellipta will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack.

Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

What other drugs will affect Anoro Ellipta

Tell your doctor about all your other medicines, especially:

atropine;

antifungal, or antiviral medicine;

monoamine oxidase inhibitors, tricyclic antidepressants, drugs that prolong QT interval;

beta-blockers;

medicine to treat depression, anxiety, mood disorders, or mental illness;

cold or allergy medicine (Benadryl and others);

medicine to treat Parkinson's disease;

medicine to treat stomach problems, motion sickness, or irritable bowel syndrome;

medicine to treat overactive bladder; or

another bronchodilator medication.

This list is not complete. Other drugs may interact with umeclidinium and vilanterol, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Popular FAQ

Trelegy has been shown in clinical studies to offer an advantage over Anoro in patients with worsening COPD symptoms. Trelegy contains an extra medicine, the inhaled corticosteroid (“steroid”) known as fluticasone, as part of a once-daily, triple therapy option for patients with COPD. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.